Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Marco

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The International Journal of Biostatistics|February 4, 2025
Bayesian covariance regression in functional data analysis with applications to functional brain imagingJohn Shamshoian, Nicholas Marco, Damla Şentürk, et al.
Statistics and Data Science in Imaging|November 14, 2025
Covariate Adjusted Functional Mixed Membership ModelsNicholas Marco, Damla Şentürk, Shafali Jeste, et al.
Journal of Computational and Graphical Statistics : a Joint Publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America|December 9, 2024
Functional Mixed Membership ModelsNicholas Marco, Damla Şentürk, Shafali Jeste, et al.
Computational Statistics & Data Analysis|September 26, 2024
Flexible Regularized Estimation in High-Dimensional Mixed Membership ModelsNicholas Marco, Damla Şentürk, Shafali Jeste, et al.
Journal of Translational Medicine|July 28, 2025
Germline microRNA-based signatures predict toxicity and response to anti-CTLA-4 therapyJoanne B Weidhaas, Kristen M McGreevy, Nicholas Marco, et al.
Clinical and Translational Radiation Oncology|March 7, 2023
Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trialAmar U Kishan, Nicholas Marco, Ting Martin Ma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 6, 2022
Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiationAmar U Kishan, Nicholas Marco, Melanie-Birte Schulz-Jaavall, et al.
Open Forum Infectious Diseases|May 2, 2022
Viral Burden and Clearance in Asymptomatic COVID-19 PatientsAvanka B Gunatilaka, Nicholas Marco, Graham H Read, et al.
Journal for Immunotherapy of Cancer|February 4, 2022
Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapyJoanne Weidhaas, Nicholas Marco, Aaron W Scheffler, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The International Journal of Biostatistics|February 4, 2025
Bayesian covariance regression in functional data analysis with applications to functional brain imagingJohn Shamshoian, Nicholas Marco, Damla Şentürk, et al.
Statistics and Data Science in Imaging|November 14, 2025
Covariate Adjusted Functional Mixed Membership ModelsNicholas Marco, Damla Şentürk, Shafali Jeste, et al.
Journal of Computational and Graphical Statistics : a Joint Publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America|December 9, 2024
Functional Mixed Membership ModelsNicholas Marco, Damla Şentürk, Shafali Jeste, et al.
Computational Statistics & Data Analysis|September 26, 2024
Flexible Regularized Estimation in High-Dimensional Mixed Membership ModelsNicholas Marco, Damla Şentürk, Shafali Jeste, et al.
Journal of Translational Medicine|July 28, 2025
Germline microRNA-based signatures predict toxicity and response to anti-CTLA-4 therapyJoanne B Weidhaas, Kristen M McGreevy, Nicholas Marco, et al.
Clinical and Translational Radiation Oncology|March 7, 2023
Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trialAmar U Kishan, Nicholas Marco, Ting Martin Ma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 6, 2022
Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiationAmar U Kishan, Nicholas Marco, Melanie-Birte Schulz-Jaavall, et al.
Open Forum Infectious Diseases|May 2, 2022
Viral Burden and Clearance in Asymptomatic COVID-19 PatientsAvanka B Gunatilaka, Nicholas Marco, Graham H Read, et al.
Journal for Immunotherapy of Cancer|February 4, 2022
Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapyJoanne Weidhaas, Nicholas Marco, Aaron W Scheffler, et al.
Pageof 1